Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Bouk CH"'
Autor:
Kodama, Hiroaki1 (AUTHOR), Murakami, Haruyasu1 (AUTHOR) ha.murakami@scchr.jp, Mamesaya, Nobuaki1 (AUTHOR), Kobayashi, Haruki1 (AUTHOR), Omori, Shota2 (AUTHOR), Wakuda, Kazushige1 (AUTHOR), Ko, Ryo1 (AUTHOR), Ono, Akira1 (AUTHOR), Kenmotsu, Hirotsugu1 (AUTHOR), Naito, Tateaki1 (AUTHOR), Matsumoto, Shingo3 (AUTHOR), Goto, Koichi3 (AUTHOR), Shimizu, Tetsuo4 (AUTHOR), Gon, Yasuhiro4 (AUTHOR), Takahashi, Toshiaki1 (AUTHOR)
Publikováno v:
Thoracic Cancer. Jul2024, Vol. 15 Issue 21, p1665-1672. 8p.
Autor:
De Abreu FB; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH., Peterson JD; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH., Deharvengt SJ; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH., Daber R; BioReference Laboratories, Elmwood Park, NJ., Sarsani VK; The Jackson Laboratory for Genomic Medicine, Farmington, CT., Spotlow V; The Jackson Laboratory for Genomic Medicine, Farmington, CT., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Konigshofer Y; Seracare Life Sciences, Gaithersburg, MD., Huang C; Seracare Life Sciences, Gaithersburg, MD., Anekella B; Seracare Life Sciences, Gaithersburg, MD., Davis L; Seracare Life Sciences, Gaithersburg, MD., Garlick RK; Seracare Life Sciences, Gaithersburg, MD., Ferreira-Gonzalez A; Virginia Commonwealth University, Richmond, VA., Dumur CI; Virginia Commonwealth University, Richmond, VA., Fernandes H; Weill Cornell Medical Center, New York City, NY; and., Haralampu S; Beta-Innovations, Belmont, MA., Tsongalis GJ; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH.
Publikováno v:
The journal of applied laboratory medicine [J Appl Lab Med] 2017 Sep 01; Vol. 2 (2), pp. 138-149.
Autor:
Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Datta V; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Yau J; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Singh RR; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Routbort MJ; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mantha GS; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Krishnamurthy S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ronski K; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Walther Z; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Finberg KE; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Canosa S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Robinson H; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Raymond A; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Le LP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Sklar JL; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Hamilton SR; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: mickey.williams@nih.gov.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2017 Mar; Vol. 19 (2), pp. 313-327. Date of Electronic Publication: 2017 Feb 07.
Autor:
Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Forbes TD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Mehaffey MG; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., McGregor PM 3rd; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Camalier CE; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Das B; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: jason.lih@nih.gov.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2016 May; Vol. 18 (3), pp. 336-349.
Autor:
Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: jason.lih@nih.gov., Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Mehaffey MG; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Forbes TD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Das B; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Walsh WD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Datta V; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Simon RM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2016 Jan; Vol. 18 (1), pp. 51-67. Date of Electronic Publication: 2015 Nov 18.
Autor:
Walsh, Elise M.1,2 (AUTHOR), Halushka, Marc K.2 (AUTHOR)
Publikováno v:
Pathobiology. 2023, Vol. 90 Issue 3, p199-208. 10p.
Publikováno v:
In Vivo; Mar/Apr2021, Vol. 35 Issue 2, p921-927, 7p
Autor:
Udar, Nitin, Lofton-Day, Catherine, Dong, Jun, Vavrek, Darcy, Jung, A. Scott, Meier, Kristen, Iyer, Anita, Slaughter, Ryan, Gutekunst, Karen, Bach, Bruce A., Peeters, Marc, Douillard, Jean-Yves
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Oct2018, Vol. 144 Issue 10, p2001-2010, 10p
Publikováno v:
Virchows Archiv: European Journal of Pathology; Oct2018, Vol. 473 Issue 4, p489-503, 15p
Autor:
Aggarwal R; University of California San Francisco, San Francisco, CA, USA. Rahul.Aggarwal@ucsf.edu., Romero GR; University of California San Francisco, San Francisco, CA, USA., Friedl V; University of California Santa Cruz, Santa Cruz, CA, USA., Weinstein A; University of California Santa Cruz, Santa Cruz, CA, USA., Foye A; University of California San Francisco, San Francisco, CA, USA., Huang J; Duke University, Durham, NC, USA., Feng F; University of California San Francisco, San Francisco, CA, USA., Stuart JM; University of California Santa Cruz, Santa Cruz, CA, USA., Small EJ; University of California Santa Cruz, Santa Cruz, CA, USA.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Mar; Vol. 24 (1), pp. 81-87. Date of Electronic Publication: 2020 Apr 14.